Para-cresyl sulfate acutely impairs vascular reactivity and induces vascular remodeling

Journal of Cellular Physiology

Volumn 230, Issue 12, 2015, Pages 2927-2935

  Gross, Priscilla ^a   Massy, Ziad A ^a,b   Henaut, Lucie ^a   Boudot, Cédric ^a   Cagnard, Joanna ^a   March, Cécilia ^a   Kamel, Saïd ^a   Drueke, Tilman B ^a   Six, Isabelle ^a  

^a UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

^b HÔPITAL AMBROISE PARÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PARA CRESYL SULFATE; PHENYLEPHRINE; RHO KINASE; SULFATE; UNCLASSIFIED DRUG; UREMIC TOXIN; 4-CRESOL SULFATE; CRESOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR MORTALITY; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; EX VIVO STUDY; HEMODIALYSIS PATIENT; HUMAN; HUMAN CELL; HYPERTENSION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RENOVASCULAR DISEASE; THORACIC AORTA; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR REMODELING; VASCULAR SMOOTH MUSCLE CELL; ANIMAL; C57BL MOUSE; CELL CULTURE; DOSE RESPONSE; DRUG EFFECTS; FEMALE; IN VITRO STUDY; METABOLISM; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TIME; TISSUE CULTURE TECHNIQUE; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

ANIMALS; AORTA, THORACIC; CELLS, CULTURED; CRESOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; IN VITRO TECHNIQUES; MICE, INBRED C57BL; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OXIDATIVE STRESS; RHO-ASSOCIATED KINASES; SIGNAL TRANSDUCTION; SULFURIC ACID ESTERS; TIME FACTORS; TISSUE CULTURE TECHNIQUES; VASCULAR REMODELING; VASOCONSTRICTION;

EID: 84939832559     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.25018     Document Type: Article

References (52)

1. Becker BF. 1993. Towards the physiological function of uric acid. Free Radic Biol Med 14:615-631.
2. Briet M, Burns KD. 2012. Chronic kidney disease and vascular remodelling: Molecular mechanisms and clinical implications. Clin Sci Lond Engl 1979:399-416.
3. Brunet P, Gondouin B, Duval-Sabatier A, Dou L, Cerini C, Dignat-George F, Jourde-Chiche N, Argiles A, Burtey S. 2011. Does uremia cause vascular dysfunction? Kidney Blood Press Res 34:284-290.
4. Bugnicourt JM, Da Silveira C, Bengrine A, Godefroy O, Baumbach G, Sevestre H, Bode-Boeger SM, Kielstein JT, Massy ZA, Chillon JM. 2011. Chronic renal failure alters endothelial function in cerebral circulation in mice. Am J Physiol Heart Circ Physiol 301:H1143-H1152.
5. Calò LA, Davis PA, Pagnin E, Dal Maso L, Maiolino G, Seccia TM, Pessina AC, Rossi GP. 2014. Increased level of p63RhoGEF and RhoA/Rho kinase activity in hypertensive patients. J Hypertens 32:331-338.
6. Denniss SG, Jeffery AJ, Rush JWE. 2010. RhoA-Rho kinase signaling mediates endothelium- and endoperoxide-dependent contractile activities characteristic of hypertensive vascular dysfunction. Am J Physiol Heart Circ Physiol 298:H1391-H1405.
7. Eftekhari A, Rahman A, Schaebel LH, Chen H, Rasmussen CV, Aalkjaer C, Buus CL, Mulvany MJ. 2007. Chronic cystamine treatment inhibits small artery remodelling in rats. J Vasc Res 44:471-482.
8. Feigenbaum J, Neuberg CA. 1941. Simplified method for the preparation of aromatic sulfuric acid esters. J Am Chem Soc 63:3529-3530.
9. Firth AL, Choi I-W, Park WS. 2012. Animal models of pulmonary hypertension: Rho kinase inhibition. Prog Biophys Mol Biol 109:67-75.
10. Itoh Y, Ezawa A, Kikuchi K, Tsuruta Y, Niwa T. 2012. Protein-bound uremic toxins in hemodialysis patients measured by liquid chromatography/tandem mass spectrometry and their effects on endothelial ROS production. Anal Bioanal Chem 403:1841-1850.
11. Janssen LJ, Tazzeo T, Zuo J, Pertens E, Keshavjee S. 2004. KCl evokes contraction of airway smooth muscle via activation of RhoA and Rho-kinase. Am J Physiol Lung Cell Mol Physiol 287:L852-L858.
12. Jin L, Ying Z, Webb RC. 2004. Activation of Rho/Rho kinase signaling pathway by reactive oxygen species in rat aorta. Am J Physiol Heart Circ Physiol 287:H1495-H1500.
13. Julian L, Olson MF. 2014. Rho-associated coiled-coil containing kinases (ROCK): Structure, regulation, and functions. Small GTPases 5:e29846.
14. Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M, Yamamori B, Feng J, Nakano T, Okawa K, Iwamatsu A, Kaibuchi K. 1996. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 273:245-248.
15. Kremer H, Baron-Menguy C, Tesse A, Gallois Y, Mercat A, Henrion D, Andriantsitohaina R, Asfar P, Meziani F. 2011. Human serum albumin improves endothelial dysfunction and survival during experimental endotoxemia: Concentration-dependent properties. Crit Care Med 39:1414-1422.
16. Lee DL, Webb RC, Jin L. 2004. Hypertension and RhoA/Rho-kinase signaling in the vasculature: Highlights from the recent literature. Hypertension 44:796-799.
17. Lin CJ, Chuang CK, Jayakumar T, Liu HL, Pan CF, Wang TJ, Chen HH, Wu CJ. 2013. Serum p-cresyl sulfate predicts cardiovascular disease and mortality in elderly hemodialysis patients. Arch Med Sci AMS 9:662-668.
18. Lin CJ, Pan CF, Chuang CK, Sun FJ, Wang DJ, Chen HH, Liu HL, Wu CJ. 2014. P-cresyl sulfate is a valuable predictor of clinical outcomes in pre-ESRD patients. Biomed Res Int 2014:526932.
19. Lin CJ, Pan CF, Liu HL, Chuang CK, Jayakumar T, Wang TJ, Chen HH, Wu CJ. 2012. The role of protein-bound uremic toxins on peripheral artery disease and vascular access failure in patients on hemodialysis. Atherosclerosis 225:173-179.
20. Llorente-Cortés V, Otero-Viñas M, Camino-López S, Llampayas O, Badimon L. 2004. Aggregated low-density lipoprotein uptake induces membrane tissue factor procoagulant activity and microparticle release in human vascular smooth muscle cells. Circulation 110:452-459.
21. Martinez-Lemus LA, Hill MA, Bolz SS, Pohl U, Meininger GA. 2004. Acute mechanoadaptation of vascular smooth muscle cells in response to continuous arteriolar vasoconstriction: Implications for functional remodeling. FASEB J 18:708-710.
22. Meijers BK, Van Kerckhoven S, Verbeke K, Dehaen W, Vanrenterghem Y, Hoylaerts MF, Evenepoel P. 2009. The uremic retention solute p-cresyl sulfate and markers of endothelial damage. Am J Kidney Dis 54:891-901.
23. Meziani F, Kremer H, Tesse A, Baron-Menguy C, Mathien C, Mostefai HA, Carusio N, Schneider F, Asfar P, Andriantsitohaina R. 2007. Human serum albumin improves arterial dysfunction during early resuscitation in mouse endotoxic model via reduced oxidative and nitrosative stresses. Am J Pathol 171:1753-1761.
24. Ming XF, Viswambharan H, Barandier C, Ruffieux J, Kaibuchi K, Rusconi S, Yang Z. 2002. Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells. Mol Cell Biol 22:8467-8477.
25. Mita M, Yanagihara H, Hishinuma S, Saito M, Walsh MP. 2002. Membrane depolarization-induced contraction of rat caudal arterial smooth muscle involves Rho-associated kinase. Biochem J 364:431-440.
26. Miyamoto Y, Iwao Y, Tasaki Y, Sato K, Ishima Y, Watanabe H, Kadowaki D, Maruyama T, Otagiri M. 2010. The uremic solute indoxyl sulfate acts as an antioxidant against superoxide anion radicals under normal-physiological conditions. FEBS Lett 584:2816-2820.
27. Miyamoto Y, Watanabe H, Noguchi T, Kotani S, Nakajima M, Kadowaki D, Otagiri M, Maruyama T. 2011. Organic anion transporters play an important role in the uptake of p-cresyl sulfate, a uremic toxin, in the kidney. Nephrol Dial Transplant 26:2498-2502.
28. Modlinger PS, Wilcox CS, Aslam S. 2004. Nitric oxide, oxidative stress, and progression of chronic renal failure. Semin Nephrol 24:354-365.
29. Mulvany MJ. 2008. Small artery remodelling in hypertension: Causes, consequences and therapeutic implications. Med Biol Eng Comput 46:461-467.
30. Nakajima M, Kataoka K, Kim-Mitsuyama S, Tanaka M, Fukagawa M, Otagiri M, Maruyama T. 2013. P-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase. Kidney Int 83:582-592.
31. New DI, Chesser AM, Thuraisingham RC, Yaqoob MM. 2004. Structural remodeling of resistance arteries in uremic hypertension. Kidney Int 65:1818-1825.
32. Nunes KP, Rigsby CS, Webb RC. 2010. RhoA/Rho-kinase and vascular diseases: What is the link? Cell Mol Life Sci 67:3823-3836.
33. Pretorius CJ, McWhinney BC, Sipinkoski B, Johnson LA, Rossi M, Campbell KL, Ungerer JP. 2013. Reference ranges and biological variation of free and total serum indoxyl- and p-cresyl sulphate measured with a rapid UPLC fluorescence detection method. Clin Chim Acta 419:122-126.
34. Sakurada S, Takuwa N, Sugimoto N, Wang Y, Seto M, Sasaki Y, Takuwa Y. 2003. Ca2+-dependent activation of Rho and Rho kinase in membrane depolarization-induced and receptor stimulation-induced vascular smooth muscle contraction. Circ Res 93:548-556.
35. Sapet C, Simoncini S, Loriod B, Puthier D, Sampol J, Nguyen C, Dignat-George F, Anfosso F. 2006. Thrombin-induced endothelial microparticle generation: Identification of a novel pathway involving ROCK-II activation by caspase-2. Blood 108:1868-1876.
36. Schepers E, Meert N, Glorieux G, Goeman J, Van der Eycken J, Vanholder R. 2007. P-cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production. Nephrol. Dial Transplant 22:592-596.
37. Seko T, Ito M, Kureishi Y, Okamoto R, Moriki N, Onishi K, Isaka N, Hartshorne DJ, Nakano T. 2003. Activation of RhoA and inhibition of myosin phosphatase as important components in hypertension in vascular smooth muscle. Circ Res 92:411-418.
38. Simoncini S, Njock MS, Robert S, Camoin-Jau L, Sampol J, Harlé JR, Nguyen C, Dignat-George F, Anfosso F. 2009. TRAIL/Apo2L mediates the release of procoagulant endothelial microparticles induced by thrombin in vitro: A potential mechanism linking inflammation and coagulation. Circ Res 104:943-951.
39. Six I, Maizel J, Barreto FC, Rangrez AY, Dupont S, Slama M, Tribouilloy C, Choukroun G, Mazière JC, Bode-Boeger S, Kielstein JT, Drüeke TB, Massy ZA. 2012. Effects of phosphate on vascular function under normal conditions and influence of the uraemic state. Cardiovasc 96:130-139.
40. Six I, Okazaki H, Gross P, Cagnard J, Boudot C, Maizel J, Drueke TB, Massy ZA. 2014. Direct, acute effects of Klotho and FGF23 on vascular smooth muscle and endothelium. PloS ONE 9:e3423.
41. Stam F, van Guldener C, Becker A, Dekker JM, Heine RJ, Bouter LM, Stehouwer CD. 2006. Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: The Hoorn study. J Am Soc Nephrol 17:537-545.
42. Stampfuss J-J, Censarek P, Fischer JW, Schrör K, Weber A-A. 2006. Rapid release of active tissue factor from human arterial smooth muscle cells under flow conditions. Arterioscler Thromb Vasc Biol 26:e34-e37.
43. Tang EH, Leung FP, Huang Y, Feletou M, So KF, Man RY, Vanhoutte PM. 2007. Calcium and reactive oxygen species increase in endothelial cells in response to releasers of endothelium-derived contracting factor. Br J Pharmacol 151:15-23.
44. Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, Tamakawa H, Yamagami K, Inui J, Maekawa M, Narumiya S. 1997. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389:990-994.
45. Vanholder R. 2003. [Uremic toxins]. Néphrologie 24:373-376.
46. Viaene L, Annaert P, de Loor H, Poesen R, Evenepoel P, Meijers B. 2013. Albumin is the main plasma binding protein for indoxyl sulfate and p-cresyl sulfate. Biopharm Drug Dispos 34:165-175.
47. Watanabe H, Miyamoto Y, Honda D, Tanaka H, Wu Q, Endo M, Noguchi T, Kadowaki D, Ishima Y, Kotani S, Nakajima M, Kataoka K, Kim-Mitsuyama S, Tanaka M, Fukagawa M, Otagiri M, Maruyama T. 2013. P-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase. Kidney Int 83:582-592.
48. Wikoff WR, Anfora AT, Liu J, Schultz PG, Lesley SA, Peters EC, Siuzdak G. 2009. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci USA 106:3698-3703.
49. Wirth A. 2010. Rho kinase and hypertension. Biochim Biophys Acta 1802:1276-1284.
50. Wolfrum S, Dendorfer A, Rikitake Y, Stalker TJ, Gong Y, Scalia R, Dominiak P, Liao JK. 2004. Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection. Arterioscler Thromb Vasc Biol 24:1842-1847.
51. Wu IW, Hsu KH, Hsu HJ, Lee CC, Sun CY, Tsai CJ, Wu MS. 2012. Serum free p-cresyl sulfate levels predict cardiovascular and all-cause mortality in elderly hemodialysis patients-a prospective cohort study. Nephrol Dial Transplant 27:1169-1175.
52. Wu-Wong JR. 2008. Endothelial dysfunction and chronic kidney disease: Treatment options. Curr Opin Investig Drugs 2000:970-982.